Depression and systemic lupus erythematosus: a systematic review.

Abstract:

OBJECTIVE:Systemic lupus erythematosus (SLE) is a chronic, relapsing-remitting autoimmune disorder that involves multiple organ systems including the central nervous system. Among the items included in the nomenclature for neuropsychiatric SLE, mood disorders have been identified. The aim of this paper is to review the clinical and psychobiological relationship between depression and SLE. METHOD:We performed a systematic search of MEDLINE, EMBASE, PsychINFO, using MeSH headings and keywords for 'depression' and 'SLE'. RESULTS:Seventeen studies reported depressive disorders, with prevalence rates in the range 17-75%. Three studies reported the most frequent symptoms, which may be represented by fatigue, weakness, somatic disorders and sleep disorders. Suicide ideation was much higher than in the general population. Nine studies analysed the relationship to SLE disease activity. The results of the available literature are contradictory. Psychobiological hypotheses have been considered in 13 studies. Among the psychobiological hypotheses which might underline the plausibility of their relationship, 'psychosocial factors' were the most frequently reported. CONCLUSIONS:Differences in assessment techniques appear to be the main explanation for the variability in findings and important methodological limitations are present in the available literature to definitively point to the prevalence of depression, type of depression and most prevalent symptoms. To date, the relationship between depression and SLE disease activity also appears controversial. Methodological limitations are present in the available literature and it would be necessary to develop evidence-based guidelines to improve the diagnosis of depression in SLE. Identification of SLE-specific biomarkers of depression also has high priority.

journal_name

Lupus

journal_title

Lupus

authors

Palagini L,Mosca M,Tani C,Gemignani A,Mauri M,Bombardieri S

doi

10.1177/0961203313477227

subject

Has Abstract

pub_date

2013-04-01 00:00:00

pages

409-16

issue

5

eissn

0961-2033

issn

1477-0962

pii

0961203313477227

journal_volume

22

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • The association of malignancy with SLE: an analysis of 150 patients under long-term review.

    abstract::We describe seven patients who developed malignancy before, after or at the onset of systemic lupus erythematosus (SLE). They comprise three cases of breast adenocarcinoma, two cases of Hodgkin's lymphoma, and one each of cholangiocarcinoma and thymoma. Only one of this group had been treated with cytotoxic agents, an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200309

    authors: Menon S,Snaith ML,Isenberg DA

    更新日期:1993-06-01 00:00:00

  • Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.

    abstract::Mesenchymal stem cells have been applied to treat graft versus host disease as they have immunosuppressive ability and can overcome the major histocompatibility complex-histocompatibility barrier. The potential of allogeneic mesenchymal stem cells in treating systemic lupus erythematosus (SLE) was investigated in this...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320928419

    authors: Liu F,Chen H,Chen T,Lau CS,Yu FX,Chen K,Chen HP,Pan RS,Chan GC,Zhang XY,Nie YJ

    更新日期:2020-07-01 00:00:00

  • A cross-sectional study of anti-DNA antibodies in the serum and IgG and IgM fraction of healthy individuals, patients with systemic lupus erythematosus and their relatives.

    abstract::Sera from healthy individuals, relatives of lupus patients, and lupus patients with active disease and in remission were screened for IgG and IgM antibodies to ssDNA and dsDNA. The serum samples were also separated into IgG and IgM fractions which were screened for DNA reactivity at dilutions equivalent to those used ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500604

    authors: Williams WM,Isenberg DA

    更新日期:1996-12-01 00:00:00

  • Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.

    abstract::HIN200 is a human IFN-inducible gene and homologous to murine IFI202 gene, which was identified as a candidate gene for SLE susceptibility in lupus mouse model. We determined these gene expressions in leukocytes from 20 SLE patients and 10 healthy controls and in renal biopsies from 29 SLE patients and 15 kidney donor...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309106699

    authors: Kimkong I,Avihingsanon Y,Hirankarn N

    更新日期:2009-10-01 00:00:00

  • GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus.

    abstract:BACKGROUND:There is no report about the association between GATA3 rs3824662 polymorphism and systemic lupus erythematosus (SLE). OBJECTIVE:To investigate the possible role of GATA3 rs3824662 polymorphism as a susceptibility risk factor for either adult SLE (aSLE) or pediatric SLE (pSLE) and to evaluate its role in the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318804894

    authors: Mosaad YM,Hammad A,Elghzaly AA,Tawhid ZME,Hammad EM,Showma A,Abdelsalam R,Elmoughy A,Fawzy IM,Anber N

    更新日期:2018-11-01 00:00:00

  • Chylous ascites and podocytopathy as the presentation of childhood lupus-an unusual occurrence.

    abstract::Systemic lupus erythematosus (SLE) is an autoimmune disorder that can affect virtually any organ. Chylous ascites as a presenting manifestation of SLE has been described in a handful of cases in adults. However, to the best of our knowledge this presentation has never been reported in the pediatric age group. Podocyto...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318817831

    authors: Pilania RK,Jindal AK,Sandesh G,Vignesh P,Suri D,Nada R,Singh S

    更新日期:2019-02-01 00:00:00

  • Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.

    abstract:INTRODUCTION:Anti-ganglioside antibodies (AGA) have been associated with several peripheral neuropathies, such as Miller-Fisher syndrome, Guillain-Barré syndrome and multifocal motor neuropathy. They have also been studied in patients with systemic lupus erythematosus (SLE), focusing on neuropsychiatric manifestations ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312436856

    authors: Labrador-Horrillo M,Martinez-Valle F,Gallardo E,Rojas-Garcia R,Ordi-Ros J,Vilardell M

    更新日期:2012-05-01 00:00:00

  • Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.

    abstract::Antiphospholipid syndrome (APS) is a distinct autoimmune prothrombotic disorder due to pathogenic autoantibodies directed against proteins that bind to phospholipids. APS is characterized by arterial and venous thrombosis and their clinical sequelae. Catastrophic antiphospholipid syndrome (CAPS) is a rare and often fa...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313491024

    authors: Rangel ML,Alghamdi I,Contreras G,Harrington T,Thomas DB,Barisoni L,Andrews D,Wolf M,Asif A,Nayer A

    更新日期:2013-07-01 00:00:00

  • Monoclonal gammopathy in systemic lupus erythematosus.

    abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100410

    authors: Porcel JM,Ordi J,Tolosa C,Selva A,Castro-Salomo A,Vilardell M

    更新日期:1992-08-01 00:00:00

  • Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.

    abstract::In vitro data showed that immunoglobulin G (IgG) from lupus nephritis (LN) patients could bind to proximal renal tubular epithelial cells (PTEC), but the clinical relevance of such binding remained unclear. Binding of IgG and subclasses to PTEC was measured by cellular ELISA (expressed as OD index) in 189 serial serum...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315598018

    authors: Yap DY,Yung S,Zhang Q,Tang C,Chan TM

    更新日期:2016-01-01 00:00:00

  • Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus.

    abstract:OBJECTIVE:The aim of our study was to investigate the efficacy of adipose-derived stem cells (ADSC) transplantation in systemic lupus erythematosus (SLE) and to determine the mechanism of ADSC transplantation. METHODS:B6.MRL/lpr mice were administered ADSC intravenously every week from age 28 to 31 weeks, while the lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318819131

    authors: Wei S,Xie S,Yang Z,Peng X,Gong L,Zhao K,Zeng K,Lai K

    更新日期:2019-02-01 00:00:00

  • Biochemical characterization of ADP-ribose polymer metabolism in SLE.

    abstract::The metabolism of poly(ADP-ribose) in peripheral blood mononuclear (PBM) cells was studied in 13 patients with systemic lupus erythematosus (SLE) and in 12 age and sex matched controls. Poly(ADP-ribose) polymerase activity was measured as the net accumulation of ADP-ribose polymers during the conversion of 32P-NAD to ...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1177/096120339600500105

    authors: Chen HY,Pertusi RM,Kirkland JB,Rubin BR,Jacobson EL

    更新日期:1996-02-01 00:00:00

  • From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?

    abstract::The heart lesions of rheumatic fever and the heart involvement in antiphospholipid syndrome (APS), have different clinical pictures. Yet, there are several common characteristics linking both diseases: 1) central nervous system (CNS) and heart involvement; 2) molecular mimicry between the a pathogen and the origin of ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2203oa

    authors: Blank M,Aron-Maor A,Shoenfeld Y

    更新日期:2005-01-01 00:00:00

  • Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.

    abstract::Systemic lupus erythematosus (SLE) is an autoantibody and immune complex mediated disease. However, it is the ensuing inflammatory process that leads to irreversible organ damage. In fact several murine models of SLE suggest that this inflammatory organ damage can be prevented even in the presence of autoantibodies. G...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu1024oa

    authors: Aringer M,Smolen JS

    更新日期:2004-01-01 00:00:00

  • Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

    abstract::The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its association with the main clinical, hematological and immunological fea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1080oa

    authors: Ramos-Casals M,Campoamor MT,Chamorro A,Salvador G,Segura S,Botero JC,Yagüe J,Cervera R,Ingelmo M,Font J

    更新日期:2004-01-01 00:00:00

  • Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.

    abstract::Herein, we investigated the risk of juvenile-onset systemic lupus erythematosus (JSLE) in children with atopic dermatitis (AD). From 2000 to 2007, 192,357 children with newly diagnosed AD and 769,428 matched non-AD controls were identified. By the end of 2008, incidences and hazard ratios (HRs) of JSLE were measured. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543920

    authors: Wei CC,Lin CL,Tsai JD,Shen TC,Sung FC

    更新日期:2014-12-01 00:00:00

  • Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE.

    abstract:OBJECTIVE:Further prospective study is needed to elucidate the etiology and natural history of systemic lupus erythematosus development. The clinical complexity of this heterogeneous disease makes study design challenging. Our objective was to ascertain useful screening factors for identifying at-risk individuals for f...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319834675

    authors: Young KA,Munroe ME,Guthridge JM,Kamen DL,Gilkensen GS,Harley JB,Weisman MH,Karp DR,Wallace DJ,James JA,Norris JM

    更新日期:2019-04-01 00:00:00

  • AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease.

    abstract::The potential of oral treatment with AVEMAR (AVEMAR), a new benzoquinone-containing fermentation product of wheat germ, on features of experimental systemic lupus erythematosus (SLE) in naive mice, induced by idiotypic manipulation, was studied. We assessed the effect of AVEMAR on the profile of autoantibody productio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301682430203

    authors: Ehrenfeld M,Blank M,Shoenfeld Y,Hidvegi M

    更新日期:2001-01-01 00:00:00

  • Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.

    abstract::Although challenging, developing evidence-based approaches to an early and accurate diagnosis of systemic lupus erythematosus is a key approach to preventing disease and lupus-associated morbidity and mortality. Advances in our understanding of preclinical and incomplete lupus erythematosus have enabled the identifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203316640367

    authors: Choi MY,Barber MR,Barber CE,Clarke AE,Fritzler MJ

    更新日期:2016-07-01 00:00:00

  • Autoimmune pancreatitis as the initial presentation of systemic lupus erythematosus.

    abstract::Pancreatitis is a relatively rare complication in systemic lupus erythematosus (SLE). Here we present a case of SLE associated with autoimmune pancreatitis. A 37-year old woman was admitted to our hospital because of fever, skin rash, proteinuria and abdominal pain. A diagnosis of SLE was made based on her clinical, l...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203306073137

    authors: Kobayashi S,Yoshida M,Kitahara T,Abe Y,Tsuchida A,Nojima Y

    更新日期:2007-01-01 00:00:00

  • Feto-maternal immune interaction at the placental level.

    abstract::A special interaction is established during pregnancy between the maternal immune system and fetal cells to allow the survival and the normal growth of the fetus. Fetal cells expressing paternal alloantigens are not recognized as foreign by the mother because of an efficient anatomic barrier and a local immunosuppress...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203304lu2010oa

    authors: Bulla R,Fischetti F,Bossi F,Tedesco F

    更新日期:2004-01-01 00:00:00

  • The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus.

    abstract::The aim of the study is to investigate whether the functional p53 codon 72 polymorphism is associated with susceptibility to SLE and its clinical features. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 90 SLE patients and 114 ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2224oa

    authors: Lee YH,Rho YH,Choi SJ,Ji JD,Song GG

    更新日期:2005-01-01 00:00:00

  • DNA methylation in systemic lupus erythematosus.

    abstract::Recent studies on epigenetics, including DNA methylation and its regulatory enzymes, seem likely to contribute to elucidation of the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE), although the relationship between DNA methylation and SLE has long been the subject of investigation. To o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu321oa

    authors: Sekigawa I,Okada M,Ogasawara H,Kaneko H,Hishikawa T,Hashimoto H

    更新日期:2003-01-01 00:00:00

  • Interstitial inflammation and long-term renal outcomes in lupus nephritis.

    abstract:INTRODUCTION:The International Society of Nephrology/Renal Pathology Society (ISN/RPS) pathological classification criteria of lupus nephritis are limited to glomerular injury. Although the tubulointerstitium is commonly involved, the importance of such involvement is not well defined. The major objective of this study...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313507986

    authors: Alsuwaida AO

    更新日期:2013-12-01 00:00:00

  • Mycophenolate mofetil in lupus nephritis.

    abstract::There is an increasing body of literature suggesting the efficacy and tolerability of mycophenolate mofetil (MMF) for the treatment of lupus nephritis. The rationale for its use is based upon its successful profile as an immunosuppressive agent for prevention of allograft rejection, as well as studies in murine models...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2061oa

    authors: Ginzler EM,Aranow C

    更新日期:2005-01-01 00:00:00

  • The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.

    abstract:OBJECTIVES:The objective of this paper is to perform the cross-cultural validation of the French version of the LupusPRO, a disease-targeted patient-reported outcome measure, among systemic lupus erythematosus (SLE) patients in Canada. METHODS:The French version of the LupusPRO and the MOS SF-36 were administered; dem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543921

    authors: Bourré-Tessier J,Clarke AE,Kosinski M,Mikolaitis-Preuss RA,Bernatsky S,Block JA,Jolly M

    更新日期:2014-12-01 00:00:00

  • The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review.

    abstract::Pericardial effusions causing pericardial tamponade are rare in patients with systemic lupus erythematosus (SLE). The goal of this study is to describe in detail the clinical and laboratory characteristics of a group of patients with pericardial effusions and pericardial tamponade secondary to SLE. We retrospectively ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308100659

    authors: Rosenbaum E,Krebs E,Cohen M,Tiliakos A,Derk CT

    更新日期:2009-06-01 00:00:00

  • Factors associated with increased white matter hyperintense lesion (WMHI) load in patients with systemic lupus erythematosus (SLE).

    abstract::Introduction White matter hyperintense (WMHI) lesions are the most common finding in magnetic resonance imaging (MRI) of the brain in patients with systemic lupus erythematosus (SLE). Objective The objective of this article is to determine the clinical factors associated with an increase in WMHI lesion load among SLE ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317707062

    authors: Shaharir SS,Osman SS,Md Rani SA,Sakthiswary R,Said MSM

    更新日期:2018-01-01 00:00:00

  • Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study.

    abstract::The relationship between disease activity, cumulative damage and self-reported quality of life was examined in 96 patients with Systematic Lupus Erythematosus (SLE). Disease activity was measured by the SLE Disease Activity Index (SLEDAI) and cumulative damage by the Systematic Lupus International Cooperating Clinics/...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600305

    authors: Hanly JG

    更新日期:1997-01-01 00:00:00

  • Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.

    abstract::To evaluate the efficacy of hydroxychloroquine (HCQ) and quinacrine (Qn) association, at two different dosages, in treatment of lupus skin lesions not responding to HCQ alone. Thirty-four patients, affected by cutaneous and systemic lupus erythematosus, were retrospectively analysed. They were treated by HCQ (5 mg/Kg/...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308101714

    authors: Cavazzana I,Sala R,Bazzani C,Ceribelli A,Zane C,Cattaneo R,Tincani A,Calzavara-Pinton PG,Franceschini F

    更新日期:2009-07-01 00:00:00